VanEck Global Hlthcr Ldrs ETF
HLTH
- A$11.54
- 0.03
- 0.26%
VanEck Global Hlthcr Ldrs ETF HLTH Strategy
The Fund gives investors access to a portfolio of leading international developed markets companies with the best growth at a reasonable price (‘GARP’) attributes from the global health care sector.
The investment objective & strategy is a summary of the investment's principal strategy as written in the prospectus. This information is pulled from the most recent product disclosure document.
ETFs News & Analysis
etfs
Young & Invested: The ETF valuation mistake investors often make
Why ETF value hunting is an illusion.
etfs
What Australian investors are buying and selling
The Australian ETF and managed fund landscape at the end of 2025.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,117.10 | 40.60 | -0.44% |
| CAC 40 | 8,131.00 | 27.16 | 0.34% |
| DAX 40 | 23,919.11 | 128.46 | 0.54% |
| Dow JONES (US) | 48,501.27 | 403.51 | -0.83% |
| FTSE 100 | 10,498.35 | 14.22 | 0.14% |
| HKSE | 25,249.48 | 518.60 | -2.01% |
| NASDAQ | 22,516.69 | 232.17 | -1.02% |
| Nikkei 225 | 54,245.54 | 2,033.51 | -3.61% |
| NZX 50 Index | 13,531.12 | 89.09 | -0.65% |
| S&P 500 | 6,816.63 | 64.99 | -0.94% |
| S&P/ASX 200 | 8,901.20 | 35.80 | -0.40% |
| SSE Composite Index | 4,082.47 | 40.20 | -0.98% |